IBS-D comprises multiple symptoms, but it is identified clinically by its dominant features of abdominal pain and diarrhea. In addition, patients with IBS-D typically experience urgency and bloating.1 While patients strongly desire improved symptom management, they often don’t clearly communicate the full extent of their condition due to focusing only on the loose stools instead of the multitude of abdominal symptoms. In addition to an open dialogue, the Patient Discussion Guide can be used to educate patients and help classify abnormal bowel movements.2
IBS-D IS A NEVER-ENDING CYCLE OF unpredictable and bothersome SYMPTOMS2
Recurrent diarrhea and abdominal pain are the main symptoms of IBS-D. People with IBS-D often experience disruptive symptoms, including cramping, frequent bowel movements, urgency, bloating, and loss of bowel control/fecal incontinence.2,4,5
When patients with IBS-D were asked to rank their most bothersome and frequent symptoms, they responded:2
Downloadable Resources for You and Your Patients
An open dialogue focused on understanding the patient’s most bothersome symptoms may help reduce treatment delays and improve treatment expectations. The resources here are designed to help start the conversation and help with patient education and treatment management.
I have problems with diarrhea and major cramps. I have been scared to leave my house and I don’t go very far from home due to the worry of IBS acting up.8
The IBS-D problems have been getting much worse. I cannot do anything without the fear of having an accident. So many milestones in my life have been ruined for me because of my problems.8
IBS is my living hell. I hate it so much.8
*Data from a survey including 3,254 IBS sufferers (1,001 with IBS-D diagnosis; 1,000 with IBS-C diagnosis; 586 with undiagnosed IBS-D; and 667 with undiagnosed IBS-C) commissioned by the American Gastroenterological Association in 2015.
IBS=irritable bowel syndrome; IBS-C=irritable bowel syndrome with constipation; IBS-D=irritable bowel syndrome with diarrhea.
References: 1. Törnblom H et al. United Euro Gastroentrol J. 2018;6(9):1417-1427. doi:10.1177/2050640618787648 2. IBS in America survey summary findings. https://www.multivu.com/players/English/7634451-aga-ibs-in-america-survey/docs/survey-findings-pdf-635473172.pdf 3. Grundmann O et al. J Gastroenterol Hepatol. 2010;25(4):691-699. doi:10.1111/j.1440-1746.2009.06120.x 4. Ballou S et al. Clin Gastroenterol and Hepatol. 2019;17:2471-2478. doi:10.1016/j.cgh.2019.08.016 5. Marquis P et al. Clin Transl Gastroenterol. 2014;5:1-13. doi:10.1038/ctg.2014.7 6. Emmanuel A et al. BMC Gastroenterology. 2020;20(127):1-10. doi:10.1186/s12876-020-01252-9 7. Singh P et al. World J Gastroenterol. 2015;21(26):8103-8109. doi:10.3748/wjg.v21.i26.8103 8. Living with IBS: Personal stories. https://www.aboutibs.org/personal-stories.html